======= RBM24 =======
== Gene Information ==
* **Official Symbol**: RBM24
* **Official Name**: RNA binding motif protein 24
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=221662|221662]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BX46|Q9BX46]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RBM24&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RBM24|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/617603|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Plays a role in myogenic differentiation by regulating MYOG levels. Binds to the 3'-UTR of MYOG mRNA and regulates its stability. {ECO:0000269|PubMed:20977548}.
|RRM 1|
|mRNA CDS binding|
|regulation of 3-UTR-mediated mRNA stabilization|
|positive regulation of 3-UTR-mediated mRNA stabilization|
|positive regulation of skeletal muscle fiber differentiation|
|regulation of skeletal muscle fiber differentiation|
|positive regulation of skeletal muscle cell differentiation|
|negative regulation of cytoplasmic translation|
|pre-mRNA intronic binding|
|sequence-specific mRNA binding|
|3-UTR-mediated mRNA destabilization|
|regulation of skeletal muscle cell differentiation|
|positive regulation of stem cell differentiation|
|positive regulation of myoblast differentiation|
|positive regulation of skeletal muscle tissue development|
|mRNA 3-UTR AU-rich region binding|
|regulation of cytoplasmic translation|
|mRNA destabilization|
|RNA destabilization|
|positive regulation of myotube differentiation|
|endocardial cushion development|
|mRNA stabilization|
|RNA stabilization|
|positive regulation of mRNA catabolic process|
|regulation of skeletal muscle tissue development|
|negative regulation of mRNA catabolic process|
|regulation of myoblast differentiation|
|regulation of myotube differentiation|
|positive regulation of striated muscle cell differentiation|
|negative regulation of RNA catabolic process|
|regulation of alternative mRNA splicing, via spliceosome|
|positive regulation of muscle organ development|
|positive regulation of striated muscle tissue development|
|positive regulation of muscle tissue development|
|mRNA 3-UTR binding|
|positive regulation of mRNA metabolic process|
|negative regulation of mRNA metabolic process|
|positive regulation of muscle cell differentiation|
|regulation of mRNA splicing, via spliceosome|
|regulation of striated muscle cell differentiation|
|regulation of stem cell differentiation|
|negative regulation of translation|
|regulation of striated muscle tissue development|
|regulation of muscle tissue development|
|regulation of muscle organ development|
|regulation of RNA splicing|
|regulation of mRNA processing|
|negative regulation of cellular amide metabolic process|
|regulation of muscle cell differentiation|
|ribonucleoprotein complex|
|mRNA binding|
|regulation of mRNA stability|
|regulation of RNA stability|
|regulation of mRNA catabolic process|
|mesenchyme development|
|negative regulation of cellular catabolic process|
|negative regulation of catabolic process|
|regulation of mRNA metabolic process|
|regulation of translation|
|positive regulation of cellular catabolic process|
|RNA splicing|
|regulation of cellular amide metabolic process|
|positive regulation of catabolic process|
|mRNA processing|
|posttranscriptional regulation of gene expression|
|heart development|
|mRNA metabolic process|
|cellular response to DNA damage stimulus|
|regulation of cellular catabolic process|
|circulatory system development|
|RNA processing|
|positive regulation of cell differentiation|
|regulation of catabolic process|
|negative regulation of cellular protein metabolic process|
|negative regulation of protein metabolic process|
|negative regulation of RNA metabolic process|
|positive regulation of developmental process|
|negative regulation of cellular macromolecule biosynthetic process|
|RNA binding|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|RNA metabolic process|
|cellular response to stress|
|negative regulation of gene expression|
|positive regulation of RNA metabolic process|
|positive regulation of multicellular organismal process|
|tissue development|
|regulation of cell differentiation|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of gene expression|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp306|Rapamycin 2μM R07 exp306]]|1.94|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 18129
* **Expression level (log2 read counts)**: -2.28
{{:chemogenomics:nalm6 dist.png?nolink |}}